.jpg)
NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for November 2011[1]. Global derivatives average daily volume (“ADV”) of 8.3 million contracts in November 2011 increased 0.7% versus the prior year with U.S. equity options increasing 10%. Cash equities ADV in November 2011 were mixed, with European cash trading ADV increasing 8.4% and U.S. cash trading ADV decreasing 9.9% from November 2010 levels.
Highlights
• NYSE Euronext global derivatives ADV in November 2011 of 8.3 million contracts increased 0.7% compared to November 2010 and increased 1.4% from October 2011 levels.
• NYSE Euronext European derivatives products ADV in November 2011 of 4.0 million contracts decreased 9.1% compared to November 2010, but increased 16.4% from October 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.3% compared to November 2010 and increased 7.3% from October 2011.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.2 million contracts in November 2011 increased 10.0% compared to November 2010 levels, but decreased 9.3% from October 2011. NYSE Euronext’s U.S. options exchanges accounted for a record 28.1% of total U.S. consolidated equity options trading in November 2011, up from 24.7% in November 2010 and up from 27.3% recorded in October 2011.
• NYSE Liffe U.S. ADV of approximately 88,500 contracts increased from 19,000 contracts in November 2010, but decreased from 95,600 contracts in October 2011.
• NYSE Euronext European cash products ADV of 1.7 million transactions in November 2011 increased 8.4% compared to November 2010, but decreased 4.1% from October 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.1 billion shares in November 2011 decreased 9.9% compared to November 2010 and decreased 15.5% compared to October 2011. NYSE Euronext’s Tape A matched market share in November 2011 was 34.1%, down from 36.1% in November 2010, but up from 33.9% in October 2011.
• There were a total of 22 trading days in Europe and 21 trading days in the U.S. in November 2011 compared to 22 trading days in Europe and 21 trading days in the U.S. in November 2010.
Derivatives Trading
European Derivatives
• NYSE Euronext European derivatives products ADV in November 2011 was 4.0 million futures and options contracts, a decrease of 9.1% from November 2010, but an increase of 16.4% from October 2011.
• The 4.0 million in European derivatives futures and options contracts ADV in November 2011 consisted of 3.1 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.9 million contracts, or 21.5%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 2.3% compared to November 2010, but increased 7.3% from October 2011.
• Year-to-date, European derivatives products ADV of 4.6 million contracts was 6.5% below prior year levels. The 4.6 million in futures and options contracts ADV year-to-date consisted of 3.4 million contracts executed through LIFFE CONNECT trading platform and 1.1 million contracts, or 24.8%, executed through Bclear.
• Total fixed income products ADV of 2.1 million contracts in November 2011 increased 6.5% from November 2010 and increased 12.4% from October 2011. Year-to-date, total fixed income products ADV of 2.3 million contracts was 1.1% below prior year levels.
• Total equity products (including Bclear) ADV of 1.8 million contracts in November 2011 decreased 23.0% compared to November 2010, but increased 23.4% from October 2011. The 1.8 million contracts in equity products ADV consisted of 1.2 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.2 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented a 30.4% decrease compared to November 2010 and 0.5 million in options contracts, which represented a 27.1% decrease compared to November 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.1 million contracts were 12.6% below prior year levels.
• Total commodities products ADV of 68,000 contracts in November 2011 increased 1.3% compared to November 2010, but decreased 14.1% compared to October 2011. Year-to-date, total commodities product ADV of 82,000 contracts was 26.4% above prior year levels.
U.S. Derivatives
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.2 million contracts in November 2011 increased 10.0% compared to November 2010, but decreased 9.3% compared to October 2011. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 20.2% above prior year levels.
• Total U.S. consolidated equity options ADV decreased 3.4% to 15.1 million contracts in November 2011 compared to November 2010 and decreased 9.3% compared to October 2011. Year-to-date, U.S. consolidated equity options ADV of 17.0 million contracts was 18.8% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for a record 28.1% of the total U.S. consolidated equity options trading in November 2011, up from 24.7% in November 2010 and up from 27.3% in October 2011.
• NYSE Liffe U.S. ADV of approximately 88,500 contracts increased from 19,000 contracts in November 2010, but decreased from 95,600 contracts in October 2011. Year-to-date, U.S. futures and futures options ADV of 80,400 contracts was 387.5% above prior year levels.
Cash Trading
European Cash
• NYSE Euronext European cash products ADV of 1.7 million transactions in November 2011 increased 8.4% compared to November 2010, but decreased 4.1% compared to October 2011.
• Year-to-date, European cash products ADV of 1.7 million transactions was 17.5% above prior year levels.
U.S. Cash
• NYSE Euronext U.S. cash products handled ADV in November 2011 decreased 9.9% to 2.1 billion shares compared to November 2010 and decreased 15.5% from October 2011.
• Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 12.3% from prior year levels.
• NYSE Euronext’s Tape A matched market share in November 2011 was 34.1%, down from 36.1% in November 2010, but up from 33.9% in October 2011.
Exchange Traded Funds
• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 320 million shares in November 2011 increased 1.6% compared to November 2010, but decreased 20.1% compared to October 2011.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 331 million shares was 3.8% below prior year levels.
[1] All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.
Please click here for the Monthly Transaction Activity Data Table.
